LexDanaLexDanabeta
Inventor

Hans-Michael Eggenweiler

Inventor
Darmstadt, DE

Overview

37→
Patents
2003–2016
Patent span
Human necessities
Primary field (CPC A)

Patents· 37 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes18%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C09KMaterials for miscellaneous applications, not provided for elsewhere1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
9,273,029'Pyridine-and pyrazine derivatives'20169,102,675'3-Cyanoaryl-1H-pyrrolo[2,3-B] pyridine derivatives'20159,045,493'Furo[3,2-b]- and thieno[3,2-b]pyridin derivatives'20158,969,335'Benzonitrile derivatives as kinase inhibitors'20158,906,930'Quinazoline derivatives'20148,816,070'Triazole derivative as an HSP 90 inhibitor'20148,791,129'Phenylquinazoline derivatives'20148,722,903'Indazole derivatives for the treatment of HSP9O-induced diseases'20148,618,285'Triazole derivatives'20138,546,565'Quinazolinamide derivatives'20138,501,754'Quinazolinamide derivatives'20138,183,279'1,3-dihydroisoindole derivatives'20128,119,795'Triazole derivatives II'20127,989,625'Thienopyridines'20117,977,343'Adenine derivatives'20117,947,696'2-amino-4-phenylquinazoline derivatives and the use thereof as HSP90 modulators'20117,943,637'Thienopyridine derivatives and the use thereof as HSP90 modulators'20117,932,401'1,5-diphenylpyrazoles'20117,906,657'1,5-diphenylpyrazoles II as HSP90 inhibitors'20117,790,723'Thiazole derivatives as phosphodiesterase IV inhibitors'20107,563,790'Pyridazine derivatives'20097,544,684'Hydrazono-malonitriles'20097,498,334'Pyrrolopyrimidines as phosphodiesterase VII inhibitors'20097,491,742'Imidazole derivatives as phosphodiesterase VII inhibitors'20097,485,639'4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1,2,4)triazin-5-one derivatives having a PDE-IV inhibiting and TNF-antagonistic effect for the treatment of cardiac diseases and allergies'20097,470,687'Aryl oximes'20087,312,328'Benzoylpyridazines'20077,141,572'Hydrazono-malonitriles'20067,135,471'Aryl oximes'20067,129,241'Pyridazine derivatives'20067,019,013'Sulfamidothienopyrimidines'20066,960,661'[7-(3-chloro-4-methoxybenzlamino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-ylmethoxy]acetic acid, synthesis thereof and intermediates used therein'20056,884,800'Imidazole compounds used as phosphodiesterase VII inhibitors'20056,780,867'Thienopyrimidines'20046,777,419'Pyrazolo 4,3-dpyrimidines'20046,737,436'Pyrrole derivatives as phosphodiesterase VII inhibitors'20046,531,498'Isoxazole derivatives to be used as phosphodiesterase VII inhibitors'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2016Patents assigned to MERCK PATENT GMBH (37)· patent assignee history
2003–2009Based in Weiterstadt, DE· patent location history
2005–2016Based in Darmstadt, DE· patent location history
2012–2016Patents assigned to EGGENWEILER HANS-MICHAEL (8)· patent assignee history
2012–2014Patents assigned to SIRRENBERG CHRISTIAN (8)· patent assignee history
2012–2014Patents assigned to BUCHSTALLER HANS-PETER (5)· patent assignee history
2012–2014Patents assigned to WOLF MICHAEL (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK PATENT GMBH372003–2016
EGGENWEILER HANS-MICHAELself82012–2016
SIRRENBERG CHRISTIAN82012–2014
BUCHSTALLER HANS-PETER52012–2014
WOLF MICHAEL42012–2014
Locations
LocationPatentsSpan
Darmstadt, DE302005–2016
Weiterstadt, DE72003–2009